Lopes EC - Search Results

1

Kaiso contributes to DNA methylation-dependent silencing of tumor suppressor genes in colon cancer cell lines.

Lopes EC, Valls E, Figueroa ME, Mazur A, Meng FG, Chiosis G, Laird PW, Schreiber-Agus N, Greally JM, Prokhortchouk E, Melnick A. Lopes EC, et al. Cancer Res. 2008 Sep 15;68(18):7258-63. doi: 10.1158/0008-5472.CAN-08-0344. Cancer Res. 2008. PMID: 18794111

2

A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.

Cerchietti LC, Lopes EC, Yang SN, Hatzi K, Bunting KL, Tsikitas LA, Mallik A, Robles AI, Walling J, Varticovski L, Shaknovich R, Bhalla KN, Chiosis G, Melnick A. Cerchietti LC, et al. Among authors: lopes ec. Nat Med. 2009 Dec;15(12):1369-76. doi: 10.1038/nm.2059. Epub 2009 Nov 22. Nat Med. 2009. PMID: 19966776 Free PMC article.

3

Pre-clinical efficacy of PU-H71, a novel HSP90 inhibitor, alone and in combination with bortezomib in Ewing sarcoma.

Ambati SR, Lopes EC, Kosugi K, Mony U, Zehir A, Shah SK, Taldone T, Moreira AL, Meyers PA, Chiosis G, Moore MA. Ambati SR, et al. Among authors: lopes ec. Mol Oncol. 2014 Mar;8(2):323-36. doi: 10.1016/j.molonc.2013.12.005. Epub 2013 Dec 15. Mol Oncol. 2014. PMID: 24388362 Free PMC article. Clinical Trial.

4

BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models.

Ambati SR, Shieh JH, Pera B, Lopes EC, Chaudhry A, Wong EW, Saxena A, Su TL, Moore MA. Ambati SR, et al. Among authors: lopes ec. Oncotarget. 2016 Jul 12;7(28):43062-43075. doi: 10.18632/oncotarget.9657. Oncotarget. 2016. PMID: 27248664 Free PMC article.

5

Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines.

García MG, Alaniz L, Lopes EC, Blanco G, Hajos SE, Alvarez E. García MG, et al. Among authors: lopes ec. Leuk Res. 2005 Dec;29(12):1425-34. doi: 10.1016/j.leukres.2005.05.004. Epub 2005 Jun 27. Leuk Res. 2005. PMID: 15982733

6

Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.

Lopes EC, Garcia M, Benavides F, Shen J, Conti CJ, Alvarez E, Hajos SE. Lopes EC, et al. Leuk Res. 2003 May;27(5):413-23. doi: 10.1016/s0145-2126(02)00216-3. Leuk Res. 2003. PMID: 12620293

7

Chromosome studies of murine T-cell lymphoid leukemia and derived cell lines.

Fabris V, Ernst G, Lopes EC, García M, Hajos S, Alvarez E, Merani S. Fabris V, et al. Among authors: lopes ec. Cancer Genet Cytogenet. 2001 Oct 1;130(1):62-7. doi: 10.1016/s0165-4608(01)00457-5. Cancer Genet Cytogenet. 2001. PMID: 11672776

8

Lopes EC, Ernst G, Aulicino P, Vanzulli S, García M, Alvarez E, Hajos SE. Lopes EC, et al. Clin Exp Metastasis. 2002;19(4):283-90. doi: 10.1023/a:1015548706673. Clin Exp Metastasis. 2002. PMID: 12090468

9

Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells.

Lopes EC, Scolnik M, Alvarez E, Hajos SE. Lopes EC, et al. Leuk Res. 2001 Jan;25(1):85-93. doi: 10.1016/s0145-2126(00)00094-1. Leuk Res. 2001. PMID: 11137565

10

Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines.

Lopes EC, García MG, Vellón L, Alvarez E, Hajos SE. Lopes EC, et al. Leuk Lymphoma. 2001 Aug;42(4):775-87. doi: 10.3109/10428190109099340. Leuk Lymphoma. 2001. PMID: 11697508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters